123 related articles for article (PubMed ID: 15523690)
1. DHPLC is superior to SSCP in screening p53 mutations in esophageal cancer tissues.
Yamanoshita O; Kubota T; Hou J; Ping YM; Zhang XL; Li XP; Li SS; Li XX; Zhu DC; Fukushima Y; Nakajima T
Int J Cancer; 2005 Mar; 114(1):74-9. PubMed ID: 15523690
[TBL] [Abstract][Full Text] [Related]
2. Superiority of denaturing high performance liquid chromatography over single-stranded conformation and conformation-sensitive gel electrophoresis for mutation detection in TSC2.
Choy YS; Dabora SL; Hall F; Ramesh V; Niida Y; Franz D; Kasprzyk-Obara J; Reeve MP; Kwiatkowski DJ
Ann Hum Genet; 1999 Sep; 63(Pt 5):383-91. PubMed ID: 10735580
[TBL] [Abstract][Full Text] [Related]
3. Somatic mutation analysis of p53 and ST7 tumor suppressor genes in gastric carcinoma by DHPLC.
Lu C; Xu HM; Ren Q; Ao Y; Wang ZN; Ao X; Jiang L; Luo Y; Zhang X
World J Gastroenterol; 2003 Dec; 9(12):2662-5. PubMed ID: 14669308
[TBL] [Abstract][Full Text] [Related]
4. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
5. DHPLC screening of cystic fibrosis gene mutations.
Ravnik-Glavac M; Atkinson A; Glavac D; Dean M
Hum Mutat; 2002 Apr; 19(4):374-83. PubMed ID: 11933191
[TBL] [Abstract][Full Text] [Related]
6. A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC.
Gross E; Arnold N; Goette J; Schwarz-Boeger U; Kiechle M
Hum Genet; 1999; 105(1-2):72-8. PubMed ID: 10480358
[TBL] [Abstract][Full Text] [Related]
7. Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus.
Phillips WA; Russell SE; Ciavarella ML; Choong DY; Montgomery KG; Smith K; Pearson RB; Thomas RJ; Campbell IG
Int J Cancer; 2006 May; 118(10):2644-6. PubMed ID: 16380997
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of the sensibility and specificity between single-stranded conformation polymorphism and denaturing high-performance liquid chromatography in screening hMSH2 and hMLH1 gene mutations in hereditary non-polyposis colorectal cancer].
Wei GH; Zhao B; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):462-4. PubMed ID: 18803051
[TBL] [Abstract][Full Text] [Related]
9. Comparison of SSCP and DHPLC for the detection of LDLR mutations in a New Zealand cohort.
Bunn CF; Lintott CJ; Scott RS; George PM
Hum Mutat; 2002 Mar; 19(3):311. PubMed ID: 11857755
[TBL] [Abstract][Full Text] [Related]
10. Denaturing high-performance liquid chromatography is a suitable method for PMM2 mutation screening in carbohydrate-deficient glycoprotein syndrome type IA patients.
Erlandson A; Stibler H; Kristiansson B; Wahlström J; Martinsson T
Genet Test; 2000; 4(3):293-7. PubMed ID: 11142762
[TBL] [Abstract][Full Text] [Related]
11. Denaturing high-performance liquid chromatography quickly and reliably detects cardiac ion channel mutations in long QT syndrome.
Ning L; Moss A; Zareba W; Robinson J; Rosero S; Ryan D; Qi M
Genet Test; 2003; 7(3):249-53. PubMed ID: 14642002
[TBL] [Abstract][Full Text] [Related]
12. Identification of exon 19 and 21 mutations of EGFR gene in Chinese patients with esophageal squamous cell carcinoma.
Cui Y; Chang D; Liu M; Lin C; Zhao B; Zhang X; Gong M
World J Surg Oncol; 2013 Oct; 11():266. PubMed ID: 24103528
[TBL] [Abstract][Full Text] [Related]
13. p53 gene alternation in squamous cell carcinoma of the esophagus detected by PCR-cold SSCP analysis.
Wang LS; Chow KC; Liu CC; Chiu JH
Proc Natl Sci Counc Repub China B; 1998 Jul; 22(3):114-21. PubMed ID: 9779600
[TBL] [Abstract][Full Text] [Related]
14. p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status.
Tolbert DM; Noffsinger AE; Miller MA; DeVoe GW; Stemmermann GN; Macdonald JS; Fenoglio-Preiser CM
Mod Pathol; 1999 Jan; 12(1):54-60. PubMed ID: 9950163
[TBL] [Abstract][Full Text] [Related]
15. p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations.
Coggi G; Bosari S; Roncalli M; Graziani D; Bossi P; Viale G; Buffa R; Ferrero S; Piazza M; Blandamura S; Segalin A; Bonavina L; Peracchia A
Cancer; 1997 Feb; 79(3):425-32. PubMed ID: 9028350
[TBL] [Abstract][Full Text] [Related]
16. Application and evaluation of denaturing HPLC for molecular genetic analysis in tuberous sclerosis.
Jones AC; Sampson JR; Hoogendoorn B; Cohen D; Cheadle JP
Hum Genet; 2000 Jun; 106(6):663-8. PubMed ID: 10942116
[TBL] [Abstract][Full Text] [Related]
17. Single-strand conformational polymorphism (SSCP)-detected p53 gene mutations are a less sensitive marker of malignancy in pleural fluids than p53 immunostaining.
Mayall F; Cursons R; Jacobson G; Chang B
Cytopathology; 1999 Aug; 10(4):259-62. PubMed ID: 10458502
[TBL] [Abstract][Full Text] [Related]
18. Validation of fluorescent SSCP analysis for sensitive detection of p53 mutations.
Moore L; Godfrey T; Eng C; Smith A; Ho R; Waldman FM
Biotechniques; 2000 May; 28(5):986-92. PubMed ID: 10818706
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous use of DGGE and DHPLC to screen TP53 mutations in cancers of the esophagus and cardia from a European high incidence area (Lower Normandy, France).
Breton J; Sichel F; Abbas A; Marnay J; Arsène D; Lechevrel M
Mutagenesis; 2003 May; 18(3):299-306. PubMed ID: 12714698
[TBL] [Abstract][Full Text] [Related]
20. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
Sarkar FH; Valdivieso M; Borders J; Yao KL; Raval MM; Madan SK; Sreepathi P; Shimoyama R; Steiger Z; Visscher DW
Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
